{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T20:39:21Z","timestamp":1775767161747,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Stomatology Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jormas.2025.102526","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T23:31:10Z","timestamp":1755041470000},"page":"102526","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"S","title":["Association of TP53 and EZH2 with salivary adenoid cystic carcinoma"],"prefix":"10.1016","volume":"126","author":[{"given":"Yongbin","family":"Di","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haolei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bohao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3204-4700","authenticated-orcid":false,"given":"Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jormas.2025.102526_bib0001","article-title":"Salivary glands adenoid cystic carcinoma: a molecular profile update and potential implications","volume":"13","author":"FJ","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.jormas.2025.102526_bib0002","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/7401458","article-title":"Adenoid Cystic Carcinoma of Salivary Glands: A Ten-Year Review and an Assessment of the Current Management, Surgery, Radiotherapy, and Chemotherapy","volume":"2023","author":"Saleh","year":"2023","journal-title":"Int J Otolaryngol"},{"issue":"3","key":"10.1016\/j.jormas.2025.102526_bib0003","doi-asserted-by":"crossref","first-page":"206","DOI":"10.14639\/0392-100X-N1379","article-title":"Adenoid cystic carcinoma. An indolent but aggressive tumour. Part A: from aetiopathogenesis to diagnosis","volume":"41","author":"Cant\u00f9","year":"2021","journal-title":"Acta Otorhinolaryngol Ital"},{"issue":"4","key":"10.1016\/j.jormas.2025.102526_bib0004","doi-asserted-by":"crossref","first-page":"296","DOI":"10.14639\/0392-100X-N1729","article-title":"Adenoid cystic carcinoma. An indolent but aggressive tumour. Part B: treatment and prognosis","volume":"41","author":"Cant\u00f9","year":"2021","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"10.1016\/j.jormas.2025.102526_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2022.105945","article-title":"Current opinions on diagnosis and treatment of adenoid cystic carcinoma","volume":"130","author":"Fang","year":"2022","journal-title":"Oral Oncol"},{"issue":"10","key":"10.1016\/j.jormas.2025.102526_bib0006","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.1172\/JCI128227","article-title":"Genetic hallmarks of recurrent\/metastatic adenoid cystic carcinoma","volume":"129","author":"Ho","year":"2019","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.jormas.2025.102526_bib0007","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/PAP.0000000000000291","article-title":"Molecular Pathology of Salivary Gland Neoplasms: Diagnostic, Prognostic, and Predictive Perspective","volume":"28","author":"Toper","year":"2021","journal-title":"Adv Anat Pathol"},{"issue":"6","key":"10.1016\/j.jormas.2025.102526_bib0008","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1093\/bib\/bbx170","article-title":"Metabolomics technology and bioinformatics for precision medicine","volume":"20","author":"Azad","year":"2019","journal-title":"Brief Bioinform"},{"issue":"11","key":"10.1016\/j.jormas.2025.102526_bib0009","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/s41587-021-01108-x","article-title":"Nanopore sequencing technology, bioinformatics and applications","volume":"39","author":"Wang","year":"2021","journal-title":"Nat Biotechnol"},{"issue":"6","key":"10.1016\/j.jormas.2025.102526_bib0010","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1093\/bib\/bby063","article-title":"A brief history of bioinformatics","volume":"20","author":"Gauthier","year":"2019","journal-title":"Brief Bioinform"},{"key":"10.1016\/j.jormas.2025.102526_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-0716-0327-7_1","article-title":"Bioinformatics for Cancer Immunotherapy","volume":"2120","author":"Holtstr\u00e4ter","year":"2020","journal-title":"Methods Mol Biol"},{"issue":"1","key":"10.1016\/j.jormas.2025.102526_bib0012","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11864-022-01043-2","article-title":"Systemic and Targeted Therapies in Adenoid Cystic Carcinoma","volume":"24","author":"Kacew","year":"2023","journal-title":"Curr Treat Options Oncol"},{"issue":"3","key":"10.1016\/j.jormas.2025.102526_bib0013","doi-asserted-by":"crossref","DOI":"10.3390\/cells12030512","article-title":"The Role of TP53 in Adaptation and Evolution","volume":"12","author":"Voskarides","year":"2023","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.jormas.2025.102526_bib0014","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1182\/bloodadvances.2021006239","article-title":"TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS\/AML","volume":"6","author":"Weinberg","year":"2022","journal-title":"Blood Adv"},{"issue":"5","key":"10.1016\/j.jormas.2025.102526_bib0015","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1136\/jclinpath-2018-205622","article-title":"Relevance of TP53 for CLL diagnostics","volume":"72","author":"Catherwood","year":"2019","journal-title":"J Clin Pathol"},{"issue":"1","key":"10.1016\/j.jormas.2025.102526_bib0016","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12862-023-02146-6","article-title":"Convergent TP53 loss and evolvability in cancer","volume":"23","author":"Mansur","year":"2023","journal-title":"BMC Ecol Evol"},{"issue":"5","key":"10.1016\/j.jormas.2025.102526_bib0017","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.celrep.2019.07.001","article-title":"Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas","volume":"28","author":"Donehower","year":"2019","journal-title":"Cell Rep"},{"issue":"4","key":"10.1016\/j.jormas.2025.102526_bib0018","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/jmcb\/mjz010","article-title":"Understanding p53 functions through p53 antibodies","volume":"11","author":"Sabapathy","year":"2019","journal-title":"J Mol Cell Biol"},{"issue":"24","key":"10.1016\/j.jormas.2025.102526_bib0019","first-page":"20","article-title":"Gain-of-Function Mutant p53: All the Roads Lead to Tumorigenesis","author":"Stein","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.jormas.2025.102526_bib0020","first-page":"133","article-title":"Vousden KH. p53, cancer and the immune response","author":"Blagih","year":"2020","journal-title":"J Cell Sci"},{"issue":"2","key":"10.1016\/j.jormas.2025.102526_bib0021","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41573-022-00571-8","article-title":"Drugging p53 in cancer: one protein, many targets","volume":"22","author":"Hassin","year":"2023","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"10.1016\/j.jormas.2025.102526_bib0022","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/jmcb\/mjy070","article-title":"Tumor suppressor p53 and metabolism","volume":"11","author":"Liu","year":"2019","journal-title":"J Mol Cell Biol"},{"issue":"1","key":"10.1016\/j.jormas.2025.102526_bib0023","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s13045-021-01169-0","article-title":"Targeting mutant p53 for cancer therapy: direct and indirect strategies","volume":"14","author":"Hu","year":"2021","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.jormas.2025.102526_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2023.102522","article-title":"Germline TP53 pathogenic variants and breast cancer: A narrative review","volume":"114","author":"Blondeaux","year":"2023","journal-title":"Cancer Treat Rev"},{"issue":"14","key":"10.1016\/j.jormas.2025.102526_bib0025","first-page":"11","article-title":"Effects of TP53 Mutations and miRs on Immune Responses in the Tumor Microenvironment Important in Pancreatic Cancer Progression","author":"McCubrey","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jormas.2025.102526_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2020.105095","article-title":"The utility of TP53 and PIK3CA mutations as prognostic biomarkers in salivary adenoid cystic carcinoma","volume":"113","author":"Adderley","year":"2021","journal-title":"Oral Oncol"},{"issue":"7","key":"10.1016\/j.jormas.2025.102526_bib0027","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s00262-020-02551-6","article-title":"Lymphocyte activation gene 3 (LAG3) protein expression on tumor-infiltrating lymphocytes in aggressive and TP53-mutated salivary gland carcinomas","volume":"69","author":"Arolt","year":"2020","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jormas.2025.102526_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114419","article-title":"Targeting EZH2 for cancer therapy: From current progress to novel strategies","volume":"238","author":"Zeng","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jormas.2025.102526_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106578","article-title":"EZH2 serves as a promising therapeutic target for fibrosis","volume":"137","author":"Zhang","year":"2023","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.jormas.2025.102526_bib0030","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1233953","article-title":"Non-canonical functions of EZH2 in cancer","volume":"13","author":"Zimmerman","year":"2023","journal-title":"Front Oncol"},{"issue":"7","key":"10.1016\/j.jormas.2025.102526_bib0031","doi-asserted-by":"crossref","DOI":"10.3390\/cells12071058","article-title":"EZH2 Methyltransferase Regulates Neuroinflammation and Neuropathic Pain","volume":"12","author":"Weng","year":"2023","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.jormas.2025.102526_bib0032","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s12032-023-02025-6","article-title":"The roles of EZH2 in cancer and its inhibitors","volume":"40","author":"Liu","year":"2023","journal-title":"Med Oncol"},{"issue":"1","key":"10.1016\/j.jormas.2025.102526_bib0033","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13045-020-00937-8","article-title":"EZH2: a novel target for cancer treatment","volume":"13","author":"Duan","year":"2020","journal-title":"J Hematol Oncol"},{"issue":"1","key":"10.1016\/j.jormas.2025.102526_bib0034","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12943-023-01786-y","article-title":"EZH2 mediated metabolic rewiring promotes tumor growth independently of histone methyltransferase activity in ovarian cancer","volume":"22","author":"Chen","year":"2023","journal-title":"Mol Cancer"},{"key":"10.1016\/j.jormas.2025.102526_bib0035","article-title":"EZH2 Inhibitors Suppress Colorectal Cancer by Regulating Macrophage Polarization in the Tumor Microenvironment","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jormas.2025.102526_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2023.102600","article-title":"Review: Targeting EZH2 in neuroblastoma","volume":"119","author":"Gao","year":"2023","journal-title":"Cancer Treat Rev"}],"container-title":["Journal of Stomatology Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246878552500312X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246878552500312X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T00:36:46Z","timestamp":1763858206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S246878552500312X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S246878552500312X"],"URL":"https:\/\/doi.org\/10.1016\/j.jormas.2025.102526","relation":{},"ISSN":["2468-7855"],"issn-type":[{"value":"2468-7855","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of TP53 and EZH2 with salivary adenoid cystic carcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Stomatology Oral and Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jormas.2025.102526","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102526"}}